Evaluation of Hyperbaric Oxygen Combined with Drugs in the Treatment of Early Brain Nerve Injury
FU Wei, LIU Fei, HUANG Rui, ZHANG Xu-dong, LIANG Jun, YAN Lei, ZHANG Ping
2022, 40(18):
8-11.
Asbtract
(
1908 )
PDF (2004KB)
(
53
)
References |
Related Articles |
Metrics
Objective To analyze the clinical effect of hyperbaric oxygen combined with pharmacotherapy in the early stage of cerebral nerve injury. Methods Fifty patients with brain nerve injury treated in the Hongqi Hospital Affiliated to Mudanjiang Medical College from February 2019 to January 2021 were selected as the research objects. They were randomly divided into the exploration group and the general group, with 25 cases in each group. The study group was treated with hyperbaric oxygen combined with nitroglycerin and aspirin enteric coated tablets, while the general group was treated with nitroglycerin and aspirin enteric coated tablets. The neurological deficit score, motor function score, swallowing function score, life ability score, neurological function improvement time, motor function improvement time, swallowing function improvement time and hospitalization time of the two groups were compared before and after treatment, and the treatment efficiency and the incidence of adverse reactions were calculated and compared. Results After treatment, compared to control group, the neural deficiency score of the investigation group was lower, whereas the movement function score, swallowing function score and living ability score were higher, which was significant in statistics(P<0.05). By comparison with control group, the improvement time of movement function, improvement time of swallowing function and hospital stay in investigation group were significantly much shorter, which was significant in statistics(P<0.05). The response rate of investigation group was higher than that of control group, while the incidence of side effects was lower, which was significant in statistics(P < 0.05). Conclusion The application of hyperbaric oxygen combined with pharmacotherapy in the treatment of cerebral nerve injury could shorten the time of symptoms, improve the deficiency of neural function, and enhance the movement function, swallowing function and living ability of patients.